FDA considers approving Pfizer vaccine booster shots

The FDA is considering authorizing Pfizer's COVID vaccine booster shot for those who are high-risk or 65 and older. It comes as the Delta variant surge appears to be peaking nationally, according to researchers advising the CDC. Nancy Chen has the latest.